© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#EASL 2011
Click Here for More Conferences
Click Here for EASL.eu
An Introduction to Hepatitis

Cholesterol Drug Statin May Improve Standard Hep C Treatment Efficacy

Medications sometimes prescribed to help manage high cholesterol levels also show promise as add-on treatments for hepatitis C, according to s...

Boceprevir Effective in Advanced Fibrosis or Cirrhosis

Merck’s HCV protease inhibitor boceprevir can be used safely and effective in people living with hepatitis C virus (HCV) with advanced...

Pharmasset’s Two-Drug Non-Interferon Combo Packs Quick Hep C Punch

A combination of two experimental once-a-day drugs active against the hepatitis C virus (HCV) is showing excellent potential, without the addi...

MUST read

Hepatitis C: The Basics
Hepatitis B: The Basics
Hepatitis A: The Basics

New Interferon Boosts Efficacy, Reduces Side Effect Risk

An experimental version of pegylated interferon, Peg-Interferon lambda, combined with ribavirin (RBV) appears to be more effective with...

Breakthrough: Non-Interferon/Ribavirin Regimen Can Cure Hep C

In what is being heralded as a hepatitis C virus (HCV) treatment research breakthrough, a clinical trial evaluating two oral medications being...

Cyclophilin Inhibitor Alisporivir Shows Promise in Phase II Hep C Study

Alisporivir, a once-daily drug at the forefront of a new class of hepatitis C virus (HCV) compounds known as cyclophilin inhibitors, significa...

Hot topics

Forums: Support and discussion
Blogs: The community speaks

Once-Daily HCV Protease Inhibitor Meets Efficacy and Safety Goals in Phase II Studies

BI 201335 is one of several protease inhibitors being developed to treat HCV.

Telaprevir Improves Viral Cure Rates After Previous Treatment Failure

People living with hepatitis C virus (HCV) whose earlier treatment was unsuccessful are more likely to achieve a sustained virologic response...
Advertisement
Treatment News
Newsfeed
Features
Ask Hep